Publications
2021
- Singh, R. K.et al. 2021. Using gold nanoparticles for enhanced intradermal delivery of poorly soluble auto-antigenic peptides. Nanomedicine: Nanotechnology, Biology and Medicine 32, article number: 102321. (10.1016/j.nano.2020.102321)
2020
- Thayer, T. C.et al. 2020. Differentiating MHC-dependent and -independent mechanisms of lymph node stromal cell regulation of Proinsulin-specific CD8+ T-Cells in type 1 diabetes. Diabetes, article number: db191050. (10.2337/db19-1050)
- Boldison, J.et al. 2020. Dendritic cells license regulatory B cells to produce IL-10 and mediate suppression of antigen-specific CD8 T cells. Cellular and Molecular Immunology 17, pp. 843 - 855. (10.1038/s41423-019-0324-z)
- Hanna, S. J.et al. 2020. Slow progressors to type 1 diabetes lose islet autoantibodies over time, have few islet antigen-specific CD8+ T cells and exhibit a distinct CD95hi B cell phenotype. Diabetologia 63, pp. 1174-1185., article number: Diabetologia volume 63, pages1174–1185(2020). (10.1007/s00125-020-05114-7)
2019
- Boldison, J.et al. 2019. Phenotypically distinct anti-insulin B cells repopulate pancreatic islets after anti-CD20 treatment in NOD mice. Diabetologia 62(11), pp. 2052-2065. (10.1007/s00125-019-04974-y)
- Pearson, J. A.et al. 2019. Altered gut microbiota activate and expand insulin B15-23-Reactive CD8+ T-Cells. Diabetes 68(5), pp. 1002-1013. (10.2337/db18-0487)
2018
- Powell, W. E.et al. 2018. Loss of CXCR3 expression on memory B cells in individuals with long-standing type 1 diabetes. Diabetologia 61, pp. 1794-1803. (10.1007/s00125-018-4651-x)
- Da Rosa, L. C.et al. 2018. B cell depletion reduces T cell activation in pancreatic islets in a murine autoimmune diabetes model. Diabetologia 61(6), pp. 1397-1410. (10.1007/s00125-018-4597-z)
2017
- Fishman, S.et al. 2017. Adoptive transfer of mRNA-Transfected T cells redirected against diabetogenic CD8 T cells can prevent diabetes. Molecular Therapy 25(2), pp. 456-464. (10.1016/j.ymthe.2016.12.007)
2016
- Pearson, J. A.et al. 2016. Proinsulin expression shapes the TCR repertoire but fails to control the development of low-avidity insulin-reactive CD8+ T cells. Diabetes 65(6), pp. 1679-1689. (10.2337/db15-1498)